Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Speed of Azelastine Nasal Spray in Seasonal Allergic Rhinitis
NCT00561717Phase 4Completed
- Sponsor
- Bayer
- Start
- Oct 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of azelastine in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Bayer. Primary endpoint: Onset of action measured by change in total nasal symptom score at 6 hours. Started Oct 2007; status: completed.
02
Drugs
azelastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00561717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561717.